Solis v. Millennium Pharmaceuticals, Inc. et al

Filing 142

ORDER signed by Chief Judge Morrison C. England, Jr., on September 3, 2014 re 140 . The hearing on the Motions 113 , 114 , 116 , 117 are CONTINUED fromSeptember 18, 2014 to October 16, 2014 at 02:00 PM in Courtroom 7 (MCE) before Chief Judge Morrison C. England Jr. The amicus briefing schedule set forth in this Courts August 15, 2014 Order (ECF No. 136 ) shall remain in effect. (Rivas, A)

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

JOHN P. BUEKER (admitted pro hac vice)
[e-mail]
ROPES & GRAY LLP
Prudential Tower, 800 Boylston Street
Boston, MA 02199-3600
Tel: [phone]
Fax: [phone]
DOUGLAS H. HALLWARD-DRIEMEIER (admitted pro hac vice)
[e-mail]
ROPES & GRAY LLP
One Metro Center 700 12th Street, NW, Suite 900
Washington, DC 20005-3948
Tel: [phone]
Fax: [phone]
LAURA G. HOEY (admitted pro hac vice)
[e-mail]
ROPES & GRAY LLP
191 North Wacker Drive, 32nd Floor
Chicago, IL 60606-4302
Tel: [phone]
Fax: [phone]
ROCKY C. TSAI
[e-mail]
ROPES & GRAY LLP
Three Embarcadero Center
San Francisco, CA 94111-4006
Tel: [phone]
Fax: [phone]
Attorneys for Defendants
SCHERING-PLOUGH CORP. AND MERCK & CO., INC.

18
19

UNITED STATES DISTRICT COURT
EASTERN DISTRICT OF CALIFORNIA

20
21

UNITED STATES OF AMERICA, ex rel.
FRANK SOLIS,

22
23

PLAINTIFF,
v.

24
25
26
27

CASE NO. 2:09-cv-3010-MCE-JFM
ORDER CONTINUING HEARING ON
DEFENDANTS’ MOTIONS TO DISMISS
AND DEFENDANT MILLENNIUM
PHARMACEUTICALS, INC.’S MOTION
TO STRIKE

MILLENNIUM PHARMACEUTICALS,
INC., SCHERING-PLOUGH CORP., and
MERCK & CO.,
DEFENDANTS.

28
[PROPOSED] ORDER CONTINUING HEARING ON DEFENDANTS’ MOTIONS TO DISMISS
AND DEFENDANT MILLENNIUM PHARMACEUTICALS, INC.’S MOTION TO STRIKE

1

Having considered the stipulation by Defendants Schering-Plough Corporation and Merck &

2

Co., Inc. (“Schering”), Defendant Millennium Pharmaceuticals, Inc. (“Millennium”), and Relator

3

Frank Solis to continue the hearing on the Motion to Dismiss filed by Schering (ECF No. 113),

4

Motions to Dismiss filed by Millennium (ECF Nos. 114 and 116), and Motion to Strike filed by

5

Millennium (ECF No. 117) (collectively, the “Motions”), the Court hereby finds that the trial

6

schedule conflict for Schering’s counsel presents good cause to continue the hearing on the Motions

7

until October 16, 2014. See ECF No. 140. The hearing on the Motions are CONTINUED from

8

September 18, 2014 to October 16, 2014. The amicus briefing schedule set forth in this Court’s

9

August 15, 2014 Order (ECF No. 136) shall remain in effect.

10
11

IT IS SO ORDERED.
Dated: September 3, 2014

12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
1
ORDER CONTINUING HEARING ON DEFENDANTS’ MOTIONS TO DISMISS AND
DEFENDANT MILLENNIUM PHARMACEUTICALS, INC.’S MOTION TO STRIKE